187 related articles for article (PubMed ID: 34058738)
1. A Melanocortin-4 Receptor Agonist Induces Skin and Hair Pigmentation in Patients with Monogenic Mutations in the Leptin-Melanocortin Pathway.
Kanti V; Puder L; Jahnke I; Krabusch PM; Kottner J; Vogt A; Richter C; Andruck A; Lechner L; Poitou C; Krude H; Gottesdiener K; Clément K; Farooqi IS; Wiegand S; Kühnen P; Blume-Peytavi U
Skin Pharmacol Physiol; 2021; 34(6):307-316. PubMed ID: 34058738
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials.
Clément K; van den Akker E; Argente J; Bahm A; Chung WK; Connors H; De Waele K; Farooqi IS; Gonneau-Lejeune J; Gordon G; Kohlsdorf K; Poitou C; Puder L; Swain J; Stewart M; Yuan G; Wabitsch M; Kühnen P;
Lancet Diabetes Endocrinol; 2020 Dec; 8(12):960-970. PubMed ID: 33137293
[TBL] [Abstract][Full Text] [Related]
3. Natural History of Obesity Due to POMC, PCSK1, and LEPR Deficiency and the Impact of Setmelanotide.
Wabitsch M; Farooqi S; Flück CE; Bratina N; Mallya UG; Stewart M; Garrison J; van den Akker E; Kühnen P
J Endocr Soc; 2022 Jun; 6(6):bvac057. PubMed ID: 35528826
[TBL] [Abstract][Full Text] [Related]
4. Melanocortin 4 Receptor Pathway Dysfunction in Obesity: Patient Stratification Aimed at MC4R Agonist Treatment.
Ayers KL; Glicksberg BS; Garfield AS; Longerich S; White JA; Yang P; Du L; Chittenden TW; Gulcher JR; Roy S; Fiedorek F; Gottesdiener K; Cohen S; North KE; Schadt EE; Li SD; Chen R; Van der Ploeg LHT
J Clin Endocrinol Metab; 2018 Jul; 103(7):2601-2612. PubMed ID: 29726959
[TBL] [Abstract][Full Text] [Related]
5. Structural analysis of setmelanotide binding to MC4R variants in comparison to wild-type receptor.
Hammad MM; Mohammad A; Alam-Eldin N; Madhu D; Al-Mulla F; Abu-Farha M; Abubaker J
Life Sci; 2022 Oct; 307():120857. PubMed ID: 35931197
[TBL] [Abstract][Full Text] [Related]
6. Rare genetic forms of obesity: From gene to therapy.
Clément K; Mosbah H; Poitou C
Physiol Behav; 2020 Dec; 227():113134. PubMed ID: 32805220
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency.
Collet TH; Dubern B; Mokrosinski J; Connors H; Keogh JM; Mendes de Oliveira E; Henning E; Poitou-Bernert C; Oppert JM; Tounian P; Marchelli F; Alili R; Le Beyec J; Pépin D; Lacorte JM; Gottesdiener A; Bounds R; Sharma S; Folster C; Henderson B; O'Rahilly S; Stoner E; Gottesdiener K; Panaro BL; Cone RD; Clément K; Farooqi IS; Van der Ploeg LHT
Mol Metab; 2017 Oct; 6(10):1321-1329. PubMed ID: 29031731
[TBL] [Abstract][Full Text] [Related]
8. Setmelanotide: a promising advancement for pediatric patients with rare forms of genetic obesity.
Trapp CM; Censani M
Curr Opin Endocrinol Diabetes Obes; 2023 Apr; 30(2):136-140. PubMed ID: 36722447
[TBL] [Abstract][Full Text] [Related]
9. Beneficial Effects of Setmelanotide in a 5-Year-Old Boy With POMC Deficiency and on His Caregivers.
Dubern B; Lourdelle A; Clément K
JCEM Case Rep; 2023 May; 1(3):luad041. PubMed ID: 37908575
[TBL] [Abstract][Full Text] [Related]
10. Melanocortin-4 Receptor Signalling: Importance for Weight Regulation and Obesity Treatment.
Kühnen P; Krude H; Biebermann H
Trends Mol Med; 2019 Feb; 25(2):136-148. PubMed ID: 30642682
[TBL] [Abstract][Full Text] [Related]
11. An intrinsic gut leptin-melanocortin pathway modulates intestinal microsomal triglyceride transfer protein and lipid absorption.
Iqbal J; Li X; Chang BH; Chan L; Schwartz GJ; Chua SC; Hussain MM
J Lipid Res; 2010 Jul; 51(7):1929-42. PubMed ID: 20164094
[TBL] [Abstract][Full Text] [Related]
12. Cardiac Phenotype and Tissue Sodium Content in Adolescents With Defects in the Melanocortin System.
Puder L; Roth S; Krabusch P; Wiegand S; Opitz R; Bald M; Flück C; Schulz E; Voss E; Markó L; Linz P; Berger F; Müller DN; Kuehne T; Litt MJ; Cone RD; Kühnen P; Kelm M
J Clin Endocrinol Metab; 2021 Aug; 106(9):2606-2616. PubMed ID: 34036349
[TBL] [Abstract][Full Text] [Related]
13. Melanocortin pathways: suppressed and stimulated melanocortin-4 receptor (MC4R).
Hainer V; Aldhoon Hainerová I; Kunešová M; Taxová Braunerová R; Zamrazilová H; Bendlová B
Physiol Res; 2020 Sep; 69(Suppl 2):S245-S254. PubMed ID: 33094623
[TBL] [Abstract][Full Text] [Related]
14. Heterozygous Genetic Variants in Autosomal Recessive Genes of the Leptin-Melanocortin Signalling Pathway Are Associated With the Development of Childhood Obesity.
Šket R; Kotnik P; Bizjan BJ; Kocen V; Mlinarič M; Tesovnik T; Debeljak M; Battelino T; Kovač J
Front Endocrinol (Lausanne); 2022; 13():832911. PubMed ID: 35574020
[TBL] [Abstract][Full Text] [Related]
15. [Melanocortin peptides : Fundamentals, translational research, clinical dermatology, and future perspectives].
Böhm M
Hautarzt; 2020 Oct; 71(10):741-751. PubMed ID: 32880662
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel LEPR mutations in Pakistani families with morbid childhood obesity.
Niazi RK; Gjesing AP; Hollensted M; Have CT; Grarup N; Pedersen O; Ullah A; Shahid G; Ahmad W; Gul A; Hansen T
BMC Med Genet; 2018 Nov; 19(1):199. PubMed ID: 30442103
[TBL] [Abstract][Full Text] [Related]
17. Setmelanotide: First Approval.
Markham A
Drugs; 2021 Feb; 81(3):397-403. PubMed ID: 33638809
[TBL] [Abstract][Full Text] [Related]
18. Activation of the brain melanocortin system is required for leptin-induced modulation of chemorespiratory function.
Bassi M; Nakamura NB; Furuya WI; Colombari DS; Menani JV; do Carmo JM; da Silva AA; Hall JE; Colombari E
Acta Physiol (Oxf); 2015 Apr; 213(4):893-901. PubMed ID: 25207799
[TBL] [Abstract][Full Text] [Related]
19. Two Cases With an Early Presented Proopiomelanocortin Deficiency-A Long-Term Follow-Up and Systematic Literature Review.
Gregoric N; Groselj U; Bratina N; Debeljak M; Zerjav Tansek M; Suput Omladic J; Kovac J; Battelino T; Kotnik P; Avbelj Stefanija M
Front Endocrinol (Lausanne); 2021; 12():689387. PubMed ID: 34177811
[TBL] [Abstract][Full Text] [Related]
20. A Setmelanotide-like Effect at MC4R Is Achieved by MC4R Dimer Separation.
Reininghaus N; Paisdzior S; Höpfner F; Jyrch S; Cetindag C; Scheerer P; Kühnen P; Biebermann H
Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36009013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
